• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

EBV-related lymphoma after long-term daratumumab treatment: a case report.

作者信息

Verpoorte-Botden Ilse P G, Minnema Monique C, Raymakers Reinier A P

机构信息

Department of Hematology, University Medical Center Utrecht, Utrecht, The Netherlands.

Department of Internal Medicine, Ziekenhuis Rivierenland Tiel, Tiel, The Netherlands.

出版信息

Blood Cancer J. 2020 Nov 4;10(11):113. doi: 10.1038/s41408-020-00379-y.

DOI:10.1038/s41408-020-00379-y
PMID:33149124
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7642364/
Abstract
摘要

相似文献

1
EBV-related lymphoma after long-term daratumumab treatment: a case report.长期使用达雷妥尤单抗治疗后发生的EB病毒相关淋巴瘤：一例报告
Blood Cancer J. 2020 Nov 4;10(11):113. doi: 10.1038/s41408-020-00379-y.
2
Epstein-Barr virus-associated B-cell lymphoma secondary to FCD-C therapy in patients with peripheral T-cell lymphoma.外周T细胞淋巴瘤患者接受FCD-C治疗后继发的爱泼斯坦-巴尔病毒相关B细胞淋巴瘤。
Int J Hematol. 2008 Nov;88(4):434-440. doi: 10.1007/s12185-008-0176-2. Epub 2008 Oct 7.
3
What are the links between Epstein-Barr virus, lymphoma, and tumor necrosis factor antagonism in rheumatoid arthritis?在类风湿性关节炎中，爱泼斯坦-巴尔病毒、淋巴瘤和肿瘤坏死因子拮抗作用之间有什么联系？
Semin Arthritis Rheum. 2005 Apr;34(5 Suppl1):31-3. doi: 10.1016/j.semarthrit.2005.01.008.
4
Epstein-Barr virus-positive lymphoma after alemtuzumab therapy for B-cell chronic lymphocytic leukemia.
Leuk Lymphoma. 2009 May;50(5):857-8. doi: 10.1080/10428190902838392.
5
Epstein-Barr virus in inflammatory bowel disease-correlation with different therapeutic regimens.炎症性肠病中的 Epstein-Barr 病毒-与不同治疗方案的相关性。
Inflamm Bowel Dis. 2013 Jul;19(8):1710-6. doi: 10.1097/MIB.0b013e318281f31c.
6
EBV-positive immunodeficiency lymphoma after alemtuzumab-CHOP therapy for peripheral T-cell lymphoma.
Blood. 2008 Aug 15;112(4):1039-41. doi: 10.1182/blood-2008-02-138800. Epub 2008 May 23.
7
Association of EBV infection with lymphomas.EB病毒感染与淋巴瘤的关联。
Acta Microbiol Pol. 2003;52(2):191-4.
8
Dynamics of Epstein-Barr virus load in pyothorax-associated lymphoma.脓胸相关性淋巴瘤中EB病毒载量的动态变化
J Med Virol. 2003 May;70(1):137-40. doi: 10.1002/jmv.10374.
9
Azathioprine-induced reversible EBV-associated Hodgkin-like lymphoma after immunosuppressive therapy for autoimmune hepatitis
.
Int J Clin Pharmacol Ther. 2018 Mar;56)(3):142-147. doi: 10.5414/CP203106.
10
Fatal adenoviral and enteroviral infections and an Epstein-Barr virus positive large B-cell lymphoma after alemtuzumab treatment in a patient with refractory Sézary syndrome.
Scand J Infect Dis. 2008;40(4):343-6. doi: 10.1080/00365540701684817.

引用本文的文献

1
Epstein-Barr Virus Driven Hodgkin's Lymphoma after a Short Course of Daratumumab Treatment for Relapsed Multiple Myeloma.在接受短期达雷妥尤单抗治疗复发多发性骨髓瘤后发生的爱泼斯坦-巴尔病毒驱动的霍奇金淋巴瘤
Case Rep Hematol. 2023 Dec 18;2023:6669174. doi: 10.1155/2023/6669174. eCollection 2023.

本文引用的文献

1
Enduring efficacy and tolerability of daratumumab in combination with lenalidomide and dexamethasone in patients with relapsed or relapsed/refractory multiple myeloma (GEN503): final results of an open-label, phase 1/2 study.达雷妥尤单抗联合来那度胺和地塞米松治疗复发或复发/难治性多发性骨髓瘤患者的持久疗效和耐受性（GEN503）：一项开放标签的1/2期研究的最终结果
Br J Haematol. 2019 Aug;186(3):e35-e39. doi: 10.1111/bjh.15879. Epub 2019 Mar 31.
2
Cytomegalovirus Reactivation in a Patient With Extensively Pretreated Multiple Myeloma During Daratumumab Treatment.达雷妥尤单抗治疗期间，一名接受过广泛预处理的多发性骨髓瘤患者出现巨细胞病毒再激活
Clin Lymphoma Myeloma Leuk. 2019 Jan;19(1):e9-e11. doi: 10.1016/j.clml.2018.10.002. Epub 2018 Oct 13.
3
Daratumumab plus lenalidomide and dexamethasone lenalidomide and dexamethasone in relapsed or refractory multiple myeloma: updated analysis of POLLUX.达雷妥尤单抗联合来那度胺和地塞米松 vs. 来那度胺和地塞米松治疗复发或难治性多发性骨髓瘤：POLLUX 更新分析。
Haematologica. 2018 Dec;103(12):2088-2096. doi: 10.3324/haematol.2018.194282. Epub 2018 Sep 20.
4
Severe cytomegalovirus enterocolitis developing following daratumumab exposure in three patients with multiple myeloma.3例多发性骨髓瘤患者在接受达雷妥尤单抗治疗后发生严重巨细胞病毒性小肠结肠炎。
Eur J Haematol. 2018 Aug 18. doi: 10.1111/ejh.13164.
5
Daratumumab, lenalidomide, and dexamethasone in East Asian patients with relapsed or refractory multiple myeloma: subgroup analyses of the phase 3 POLLUX study.达雷妥尤单抗、来那度胺和地塞米松治疗复发或难治性多发性骨髓瘤的东亚患者：III 期 POLLUX 研究的亚组分析。
Blood Cancer J. 2018 May 1;8(4):41. doi: 10.1038/s41408-018-0071-x.
6
Daratumumab plus Bortezomib, Melphalan, and Prednisone for Untreated Myeloma.达雷妥尤单抗联合硼替佐米、美法仑和泼尼松治疗未经治疗的多发性骨髓瘤。
N Engl J Med. 2018 Feb 8;378(6):518-528. doi: 10.1056/NEJMoa1714678. Epub 2017 Dec 12.
7
Daratumumab, Bortezomib, and Dexamethasone for Multiple Myeloma.达雷妥尤单抗、硼替佐米和地塞米松治疗多发性骨髓瘤。
N Engl J Med. 2016 Aug 25;375(8):754-66. doi: 10.1056/NEJMoa1606038.
8
Phase 1/2 study of daratumumab, lenalidomide, and dexamethasone for relapsed multiple myeloma.达雷妥尤单抗、来那度胺和地塞米松用于复发多发性骨髓瘤的1/2期研究。
Blood. 2016 Oct 6;128(14):1821-1828. doi: 10.1182/blood-2016-07-726729. Epub 2016 Aug 16.
9
Lenalidomide, Thalidomide, and Pomalidomide Reactivate the Epstein-Barr Virus Lytic Cycle through Phosphoinositide 3-Kinase Signaling and Ikaros Expression.来那度胺、沙利度胺和泊马度胺通过磷酸肌醇3激酶信号传导和IKAROS表达重新激活爱泼斯坦-巴尔病毒裂解周期。
Clin Cancer Res. 2016 Oct 1;22(19):4901-4912. doi: 10.1158/1078-0432.CCR-15-2242. Epub 2016 Jun 13.
10
Clinical efficacy of daratumumab monotherapy in patients with heavily pretreated relapsed or refractory multiple myeloma.达雷妥尤单抗单药治疗在多次预处理的复发或难治性多发性骨髓瘤患者中的临床疗效。
Blood. 2016 Jul 7;128(1):37-44. doi: 10.1182/blood-2016-03-705210. Epub 2016 May 23.